Literature DB >> 6024298

Metabolism of radioactive cyclophosphamide. Animal tests and clinical studies.

E H Graul, E Schaumlöffel, H Hundeshagen, H Wilmanns, G Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6024298     DOI： 10.1002/1097-0142(1967)20:5<896::aid-cncr2820200551>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

1.  EFFECT OF DONOR PRETREATMENT WITH CYCLOPHOSPHAMIDE ON THE MECHANICAL PERFORMANCE OF THE ISOLATED HEART.

Authors:  S Pitzele; S Sze
Journal:  Cardiovasc Dis       Date:  1976

2.  Protective and immunostimulating activity of a low dose of cyclophosphamide in the experimental infection of mice with foot-and-mouth disease virus.

Authors:  E L Portiansky; W M DiGirolamo; R P Laguens
Journal:  Experientia       Date:  1989-01-15

3.  [Ig-A-myeloma with cerebrospinal manifestation. Systematic localisation in pie mater and Virchow-Robin spaces, excessive increase of Ig-A in cerebrospinal fluid (author's transl)].

Authors:  W Dahlmann; F Grunwald
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974

4.  Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat.

Authors:  S Genka; J Deutsch; P L Stahle; U H Shetty; V John; C Robinson; S I Rapoport; N H Greig
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 5.  A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.

Authors:  D J Stewart
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Uptake of bleomycin by human brain tumours.

Authors:  T Hayakawa; Y Ushio; K Morimoto; H Hasegawa; H Mogami
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-04       Impact factor: 10.154

7.  Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis.

Authors:  W W Shih; R W Baumhefner; W W Tourtellotte; C M Haskell; E L Korn; J L Fahey
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

8.  Pharmacokinetics of cyclophosphamide in man.

Authors:  J L Cohen; J Y Jao; W J Jusko
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

Review 9.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

10.  Distribution and pharmacokinetics of cyclophosphamide in the rat.

Authors:  M R Talha; H J Rogers; J R Trounce
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.